Global HER-2 Targeted Drugs for Breast Cancer Market Size, Status and Forecast 2024-2031

Report ID: 918315 | Published Date: Sep 2024 | No. of Page: 108 | Base Year: 2023 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global HER-2 Targeted Drugs for Breast Cancer Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Trastuzumab
        1.2.3 Pertuzumab
        1.2.4 Lapatinib
        1.2.5 Neratinib
        1.2.6 Trastuzumab Emtansine
        1.2.7 Pyrotinib
        1.2.8 Other
    1.3 Market by Application
        1.3.1 Global HER-2 Targeted Drugs for Breast Cancer Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Drug Center
        1.3.5 Other
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global HER-2 Targeted Drugs for Breast Cancer Market Perspective (2016-2027)
    2.2 HER-2 Targeted Drugs for Breast Cancer Growth Trends by Regions
        2.2.1 HER-2 Targeted Drugs for Breast Cancer Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 HER-2 Targeted Drugs for Breast Cancer Historic Market Share by Regions (2016-2021)
        2.2.3 HER-2 Targeted Drugs for Breast Cancer Forecasted Market Size by Regions (2022-2027)
    2.3 HER-2 Targeted Drugs for Breast Cancer Industry Dynamic
        2.3.1 HER-2 Targeted Drugs for Breast Cancer Market Trends
        2.3.2 HER-2 Targeted Drugs for Breast Cancer Market Drivers
        2.3.3 HER-2 Targeted Drugs for Breast Cancer Market Challenges
        2.3.4 HER-2 Targeted Drugs for Breast Cancer Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top HER-2 Targeted Drugs for Breast Cancer Players by Revenue
        3.1.1 Global Top HER-2 Targeted Drugs for Breast Cancer Players by Revenue (2016-2021)
        3.1.2 Global HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Players (2016-2021)
    3.2 Global HER-2 Targeted Drugs for Breast Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by HER-2 Targeted Drugs for Breast Cancer Revenue
    3.4 Global HER-2 Targeted Drugs for Breast Cancer Market Concentration Ratio
        3.4.1 Global HER-2 Targeted Drugs for Breast Cancer Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by HER-2 Targeted Drugs for Breast Cancer Revenue in 2020
    3.5 HER-2 Targeted Drugs for Breast Cancer Key Players Head office and Area Served
    3.6 Key Players HER-2 Targeted Drugs for Breast Cancer Product Solution and Service
    3.7 Date of Enter into HER-2 Targeted Drugs for Breast Cancer Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 HER-2 Targeted Drugs for Breast Cancer Breakdown Data by Type
    4.1 Global HER-2 Targeted Drugs for Breast Cancer Historic Market Size by Type (2016-2021)
    4.2 Global HER-2 Targeted Drugs for Breast Cancer Forecasted Market Size by Type (2022-2027)

5 HER-2 Targeted Drugs for Breast Cancer Breakdown Data by Application
    5.1 Global HER-2 Targeted Drugs for Breast Cancer Historic Market Size by Application (2016-2021)
    5.2 Global HER-2 Targeted Drugs for Breast Cancer Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027)
    6.2 North America HER-2 Targeted Drugs for Breast Cancer Market Size by Type
        6.2.1 North America HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2016-2021)
        6.2.2 North America HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2022-2027)
        6.2.3 North America HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2016-2027)
    6.3 North America HER-2 Targeted Drugs for Breast Cancer Market Size by Application
        6.3.1 North America HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2016-2021)
        6.3.2 North America HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2022-2027)
        6.3.3 North America HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2016-2027)
    6.4 North America HER-2 Targeted Drugs for Breast Cancer Market Size by Country
        6.4.1 North America HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2016-2021)
        6.4.2 North America HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027)
    7.2 Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Type
        7.2.1 Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2016-2021)
        7.2.2 Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2022-2027)
        7.2.3 Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2016-2027)
    7.3 Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Application
        7.3.1 Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2016-2021)
        7.3.2 Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2022-2027)
        7.3.3 Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2016-2027)
    7.4 Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Country
        7.4.1 Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2016-2021)
        7.4.2 Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027)
    8.2 Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size by Type
        8.2.1 Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2016-2027)
    8.3 Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size by Application
        8.3.1 Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2016-2027)
    8.4 Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size by Region
        8.4.1 Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027)
    9.2 Latin America HER-2 Targeted Drugs for Breast Cancer Market Size by Type
        9.2.1 Latin America HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2016-2021)
        9.2.2 Latin America HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2022-2027)
        9.2.3 Latin America HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2016-2027)
    9.3 Latin America HER-2 Targeted Drugs for Breast Cancer Market Size by Application
        9.3.1 Latin America HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2016-2021)
        9.3.2 Latin America HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2022-2027)
        9.3.3 Latin America HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2016-2027)
    9.4 Latin America HER-2 Targeted Drugs for Breast Cancer Market Size by Country
        9.4.1 Latin America HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2016-2021)
        9.4.2 Latin America HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027)
    10.2 Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Type
        10.2.1 Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2016-2027)
    10.3 Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Application
        10.3.1 Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2016-2027)
    10.4 Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Country
        10.4.1 Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Roche
        11.1.1 Roche Company Details
        11.1.2 Roche Business Overview
        11.1.3 Roche HER-2 Targeted Drugs for Breast Cancer Introduction
        11.1.4 Roche Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021)
        11.1.5 Roche Recent Development
    11.2 Chugai Pharmaceutical
        11.2.1 Chugai Pharmaceutical Company Details
        11.2.2 Chugai Pharmaceutical Business Overview
        11.2.3 Chugai Pharmaceutical HER-2 Targeted Drugs for Breast Cancer Introduction
        11.2.4 Chugai Pharmaceutical Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021)
        11.2.5 Chugai Pharmaceutical Recent Development
    11.3 GlaxoSmithKline
        11.3.1 GlaxoSmithKline Company Details
        11.3.2 GlaxoSmithKline Business Overview
        11.3.3 GlaxoSmithKline HER-2 Targeted Drugs for Breast Cancer Introduction
        11.3.4 GlaxoSmithKline Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021)
        11.3.5 GlaxoSmithKline Recent Development
    11.4 Novartis
        11.4.1 Novartis Company Details
        11.4.2 Novartis Business Overview
        11.4.3 Novartis HER-2 Targeted Drugs for Breast Cancer Introduction
        11.4.4 Novartis Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021)
        11.4.5 Novartis Recent Development
    11.5 Pfizer
        11.5.1 Pfizer Company Details
        11.5.2 Pfizer Business Overview
        11.5.3 Pfizer HER-2 Targeted Drugs for Breast Cancer Introduction
        11.5.4 Pfizer Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021)
        11.5.5 Pfizer Recent Development
    11.6 CANbridge
        11.6.1 CANbridge Company Details
        11.6.2 CANbridge Business Overview
        11.6.3 CANbridge HER-2 Targeted Drugs for Breast Cancer Introduction
        11.6.4 CANbridge Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021)
        11.6.5 CANbridge Recent Development
    11.7 Puma Biotechnology
        11.7.1 Puma Biotechnology Company Details
        11.7.2 Puma Biotechnology Business Overview
        11.7.3 Puma Biotechnology HER-2 Targeted Drugs for Breast Cancer Introduction
        11.7.4 Puma Biotechnology Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021)
        11.7.5 Puma Biotechnology Recent Development
    11.8 Hengrui Medicine
        11.8.1 Hengrui Medicine Company Details
        11.8.2 Hengrui Medicine Business Overview
        11.8.3 Hengrui Medicine HER-2 Targeted Drugs for Breast Cancer Introduction
        11.8.4 Hengrui Medicine Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021)
        11.8.5 Hengrui Medicine Recent Development
    11.9 Beacon Pharmaceuticals Limited
        11.9.1 Beacon Pharmaceuticals Limited Company Details
        11.9.2 Beacon Pharmaceuticals Limited Business Overview
        11.9.3 Beacon Pharmaceuticals Limited HER-2 Targeted Drugs for Breast Cancer Introduction
        11.9.4 Beacon Pharmaceuticals Limited Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021)
        11.9.5 Beacon Pharmaceuticals Limited Recent Development
    11.10 Hetero Drugs 
        11.10.1 Hetero Drugs  Company Details
        11.10.2 Hetero Drugs  Business Overview
        11.10.3 Hetero Drugs  HER-2 Targeted Drugs for Breast Cancer Introduction
        11.10.4 Hetero Drugs  Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021)
        11.10.5 Hetero Drugs  Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global HER-2 Targeted Drugs for Breast Cancer Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Trastuzumab
    Table 3. Key Players of Pertuzumab
    Table 4. Key Players of Lapatinib
    Table 5. Key Players of Neratinib
    Table 6. Key Players of Trastuzumab Emtansine
    Table 7. Key Players of Pyrotinib
    Table 8. Key Players of Other
    Table 9. Global HER-2 Targeted Drugs for Breast Cancer Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 10. Global HER-2 Targeted Drugs for Breast Cancer Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 11. Global HER-2 Targeted Drugs for Breast Cancer Market Size by Regions (2016-2021) & (US$ Million)
    Table 12. Global HER-2 Targeted Drugs for Breast Cancer Market Share by Regions (2016-2021)
    Table 13. Global HER-2 Targeted Drugs for Breast Cancer Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 14. Global HER-2 Targeted Drugs for Breast Cancer Market Share by Regions (2022-2027)
    Table 15. HER-2 Targeted Drugs for Breast Cancer Market Trends
    Table 16. HER-2 Targeted Drugs for Breast Cancer Market Drivers
    Table 17. HER-2 Targeted Drugs for Breast Cancer Market Challenges
    Table 18. HER-2 Targeted Drugs for Breast Cancer Market Restraints
    Table 19. Global HER-2 Targeted Drugs for Breast Cancer Revenue by Players (2016-2021) & (US$ Million)
    Table 20. Global HER-2 Targeted Drugs for Breast Cancer Market Share by Players (2016-2021)
    Table 21. Global Top HER-2 Targeted Drugs for Breast Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HER-2 Targeted Drugs for Breast Cancer as of 2020)
    Table 22. Ranking of Global Top HER-2 Targeted Drugs for Breast Cancer Companies by Revenue (US$ Million) in 2020
    Table 23. Global 5 Largest Players Market Share by HER-2 Targeted Drugs for Breast Cancer Revenue (CR5 and HHI) & (2016-2021)
    Table 24. Key Players Headquarters and Area Served
    Table 25. Key Players HER-2 Targeted Drugs for Breast Cancer Product Solution and Service
    Table 26. Date of Enter into HER-2 Targeted Drugs for Breast Cancer Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2016-2021) (US$ Million)
    Table 29. Global HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Type (2016-2021)
    Table 30. Global HER-2 Targeted Drugs for Breast Cancer Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 31. Global HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 32. Global HER-2 Targeted Drugs for Breast Cancer Market Size Share by Application (2016-2021) & (US$ Million)
    Table 33. Global HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Application (2016-2021)
    Table 34. Global HER-2 Targeted Drugs for Breast Cancer Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 35. Global HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 36. North America HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2016-2021) (US$ Million)
    Table 37. North America HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2022-2027) & (US$ Million)
    Table 38. North America HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2016-2021) (US$ Million)
    Table 39. North America HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2022-2027) & (US$ Million)
    Table 40. North America HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2016-2021) & (US$ Million) 
    Table 41. North America HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2022-2027) & (US$ Million) 
    Table 42. Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2016-2021) (US$ Million)
    Table 43. Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2022-2027) & (US$ Million)
    Table 44. Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2016-2021) (US$ Million)
    Table 45. Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2022-2027) & (US$ Million)
    Table 46. Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2016-2021) & (US$ Million) 
    Table 47. Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2022-2027) & (US$ Million) 
    Table 48. Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2016-2021) (US$ Million)
    Table 49. Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2022-2027) & (US$ Million)
    Table 50. Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2016-2021) (US$ Million)
    Table 51. Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2022-2027) & (US$ Million)
    Table 52. Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size by Region (2016-2021) & (US$ Million) 
    Table 53. Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size by Region (2022-2027) & (US$ Million) 
    Table 54. Latin America HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2016-2021) (US$ Million)
    Table 55. Latin America HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2022-2027) & (US$ Million)
    Table 56. Latin America HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2016-2021) (US$ Million)
    Table 57. Latin America HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2022-2027) & (US$ Million)
    Table 58. Latin America HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2016-2021) & (US$ Million) 
    Table 59. Latin America HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2022-2027) & (US$ Million) 
    Table 60. Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2016-2021) (US$ Million)
    Table 61. Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2022-2027) & (US$ Million)
    Table 62. Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2016-2021) (US$ Million)
    Table 63. Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2022-2027) & (US$ Million)
    Table 64. Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2016-2021) & (US$ Million) 
    Table 65. Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2022-2027) & (US$ Million) 
    Table 66. Roche Company Details
    Table 67. Roche Business Overview
    Table 68. Roche HER-2 Targeted Drugs for Breast Cancer Product
    Table 69. Roche Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021) & (US$ Million)
    Table 70. Roche Recent Development
    Table 71. Chugai Pharmaceutical Company Details
    Table 72. Chugai Pharmaceutical Business Overview
    Table 73. Chugai Pharmaceutical HER-2 Targeted Drugs for Breast Cancer Product
    Table 74. Chugai Pharmaceutical Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021) & (US$ Million)
    Table 75. Chugai Pharmaceutical Recent Development
    Table 76. GlaxoSmithKline Company Details
    Table 77. GlaxoSmithKline Business Overview
    Table 78. GlaxoSmithKline HER-2 Targeted Drugs for Breast Cancer Product
    Table 79. GlaxoSmithKline Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021) & (US$ Million)
    Table 80. GlaxoSmithKline Recent Development
    Table 81. Novartis Company Details
    Table 82. Novartis Business Overview
    Table 83. Novartis HER-2 Targeted Drugs for Breast Cancer Product
    Table 84. Novartis Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021) & (US$ Million)
    Table 85. Novartis Recent Development
    Table 86. Pfizer Company Details
    Table 87. Pfizer Business Overview
    Table 88. Pfizer HER-2 Targeted Drugs for Breast Cancer Product
    Table 89. Pfizer Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021) & (US$ Million)
    Table 90. Pfizer Recent Development
    Table 91. CANbridge Company Details
    Table 92. CANbridge Business Overview
    Table 93. CANbridge HER-2 Targeted Drugs for Breast Cancer Product
    Table 94. CANbridge Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021) & (US$ Million)
    Table 95. CANbridge Recent Development
    Table 96. Puma Biotechnology Company Details
    Table 97. Puma Biotechnology Business Overview
    Table 98. Puma Biotechnology HER-2 Targeted Drugs for Breast Cancer Product
    Table 99. Puma Biotechnology Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021) & (US$ Million)
    Table 100. Puma Biotechnology Recent Development
    Table 101. Hengrui Medicine Company Details
    Table 102. Hengrui Medicine Business Overview
    Table 103. Hengrui Medicine Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021) & (US$ Million)
    Table 104. Hengrui Medicine Recent Development
    Table 105. Beacon Pharmaceuticals Limited Company Details
    Table 106. Beacon Pharmaceuticals Limited Business Overview
    Table 107. Beacon Pharmaceuticals Limited HER-2 Targeted Drugs for Breast Cancer Product
    Table 108. Beacon Pharmaceuticals Limited Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021) & (US$ Million)
    Table 109. Beacon Pharmaceuticals Limited Recent Development
    Table 110. Hetero Drugs  Company Details
    Table 111. Hetero Drugs  Business Overview
    Table 112. Hetero Drugs  HER-2 Targeted Drugs for Breast Cancer Product
    Table 113. Hetero Drugs  Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021) & (US$ Million)
    Table 114. Hetero Drugs  Recent Development
    Table 115. Research Programs/Design for This Report
    Table 116. Key Data Information from Secondary Sources
    Table 117. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global HER-2 Targeted Drugs for Breast Cancer Market Share by Type: 2020 VS 2027
    Figure 2. Trastuzumab Features
    Figure 3. Pertuzumab Features
    Figure 4. Lapatinib Features
    Figure 5. Neratinib Features
    Figure 6. Trastuzumab Emtansine Features
    Figure 7. Pyrotinib Features
    Figure 8. Other Features
    Figure 9. Global HER-2 Targeted Drugs for Breast Cancer Market Share by Application: 2020 VS 2027
    Figure 10. Hospital Case Studies
    Figure 11. Clinic Case Studies
    Figure 12. Drug Center Case Studies
    Figure 13. Other Case Studies
    Figure 14. HER-2 Targeted Drugs for Breast Cancer Report Years Considered
    Figure 15. Global HER-2 Targeted Drugs for Breast Cancer Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 16. Global HER-2 Targeted Drugs for Breast Cancer Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 17. Global HER-2 Targeted Drugs for Breast Cancer Market Share by Regions: 2020 VS 2027
    Figure 18. Global HER-2 Targeted Drugs for Breast Cancer Market Share by Regions (2022-2027)
    Figure 19. Global HER-2 Targeted Drugs for Breast Cancer Market Share by Players in 2020
    Figure 20. Global Top HER-2 Targeted Drugs for Breast Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HER-2 Targeted Drugs for Breast Cancer as of 2020
    Figure 21. The Top 10 and 5 Players Market Share by HER-2 Targeted Drugs for Breast Cancer Revenue in 2020
    Figure 22. Global HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Type (2016-2021)
    Figure 23. Global HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Type (2022-2027)
    Figure 24. North America HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. North America HER-2 Targeted Drugs for Breast Cancer Market Share by Type (2016-2027)
    Figure 26. North America HER-2 Targeted Drugs for Breast Cancer Market Share by Application (2016-2027)
    Figure 27. North America HER-2 Targeted Drugs for Breast Cancer Market Share by Country (2016-2027)
    Figure 28. United States HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. Canada HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. Europe HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Europe HER-2 Targeted Drugs for Breast Cancer Market Share by Type (2016-2027)
    Figure 32. Europe HER-2 Targeted Drugs for Breast Cancer Market Share by Application (2016-2027)
    Figure 33. Europe HER-2 Targeted Drugs for Breast Cancer Market Share by Country (2016-2027)
    Figure 34. Germany HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. France HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. U.K. HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Italy HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Russia HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Nordic HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Share by Type (2016-2027)
    Figure 42. Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Share by Application (2016-2027)
    Figure 43. Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Share by Region (2016-2027)
    Figure 44. China HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Japan HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. South Korea HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Southeast Asia HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. India HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Australia HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Latin America HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Latin America HER-2 Targeted Drugs for Breast Cancer Market Share by Type (2016-2027)
    Figure 52. Latin America HER-2 Targeted Drugs for Breast Cancer Market Share by Application (2016-2027)
    Figure 53. Latin America HER-2 Targeted Drugs for Breast Cancer Market Share by Country (2016-2027)
    Figure 54. Mexico HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Brazil HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Share by Type (2016-2027)
    Figure 58. Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Share by Application (2016-2027)
    Figure 59. Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Share by Country (2016-2027)
    Figure 60. Turkey HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 61. Saudi Arabia HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 62. UAE HER-2 Targeted Drugs for Breast Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 63. Roche Revenue Growth Rate in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021)
    Figure 64. Chugai Pharmaceutical Revenue Growth Rate in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021)
    Figure 65. GlaxoSmithKline Revenue Growth Rate in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021)
    Figure 66. Novartis Revenue Growth Rate in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021)
    Figure 67. Pfizer Revenue Growth Rate in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021)
    Figure 68. CANbridge Revenue Growth Rate in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021)
    Figure 69. Puma Biotechnology Revenue Growth Rate in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021)
    Figure 70. Hengrui Medicine Revenue Growth Rate in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021)
    Figure 71. Beacon Pharmaceuticals Limited Revenue Growth Rate in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021)
    Figure 72. Hetero Drugs  Revenue Growth Rate in HER-2 Targeted Drugs for Breast Cancer Business (2016-2021)
    Figure 73. Bottom-up and Top-down Approaches for This Report
    Figure 74. Data Triangulation
    Figure 75. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche
Chugai Pharmaceutical
GlaxoSmithKline
Novartis
Pfizer
CANbridge
Puma Biotechnology
Hengrui Medicine
Beacon Pharmaceuticals Limited
Hetero Drugs 
Frequently Asked Questions
HER-2 Targeted Drugs for Breast Cancer report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
HER-2 Targeted Drugs for Breast Cancer report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
HER-2 Targeted Drugs for Breast Cancer report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports